Eisai in Switzerland
Eisai Pharma AG is the Swiss subsidiary of the Eisai Group, a research-based pharmaceutical company headquartered in Tokyo, Japan. Eisai has been marketing and distributing its medicines for the Swiss market from Zurich since 2005. Our employees work in the areas of sales & marketing, medical affairs, regulatory affairs, finance and pharmaceutical services.
The focus is on the fields of neurology and oncology.
For our employees, their work is not just a “job”: we are committed to our corporate philosophy and are committed to ensuring that people with serious illnesses have access to the medicines they need.
EMEA region
We are part of an international network of research and development facilities, production sites and sales offices. We are part of the EMEA region (Europe, Middle East, Africa, Russia and Australia / Oceania), which is headquartered in Hatfield (UK).
You are currently viewing a placeholder content from Default. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
Healthcare professional circles
Are you a healthcare professional looking for information on our preparations?
For legal reasons, we are only permitted to make information on prescription-only medicines available to specialists (e.g. doctors, pharmacists). For information on our preparations, please contact us directly or visit the homepage of the Swiss Agency for Therapeutic Products Swissmedic.
